Podcasts about Crna

What if CRNA school interviews have been measuring the wrong things all along? In this episode of Airway Exchange, Vicente Gonzalez, DNP, CRNA and Ann Miller, DNP, CRNA, faculty from Florida International University, break down their groundbreaking new admissions interview process designed to assess what traditional interviews often miss: resilience, adaptability, teamwork, critical thinking, and emotional regulation. Here's some of what you'll hear in this episode:

Most CRNAs have never heard the name Florence Boswell. But maybe they should have. In this fascinating historical episode of Beyond the Mask, former AANA president Debra Malina, CRNA, MBA, DNSc, and Sandy Ouellette, CRNA, uncover the remarkable story of Florence Boswell, a nurse anesthetist, aviation pioneer, charter member of the National Association of Nurse Anesthetists, and one of the earliest women pilots in America. Here's some of what you'll hear in this episode:

What really happens after CRNA school ends? In this episode of Grade 1 View, former host Kevin Chem, DNP, CRNA returns to the show nearly a year into practice to talk honestly about the transition from SRNA to CRNA, from the stress of boards and credentialing to the emotional reality of walking into the OR independently for the first time. Here's some of what we discuss in this episode:

What happens when anesthesia providers from around the world come together in one place? In this special recap episode of Beyond the Mask, Sharon is joined by Erin Foley, DNAP, MSNA, CRNA, FAANA, and TxANA Vice President Jennifer Andersen, MSNA, CRNA to look back on their experience attending the International Federation of Nurse Anesthetists (IFNA) Congress in Australia. Find out what we learned, what surprised us, and why these meetings matter so much to our profession. Here's some of what you'll hear in this episode:

Welcome to the Atomic Anesthesia podcast hosted by CRNA professor Dr. Rhea Temmermand and Co-Founder Sachi Lord. On this show, you'll hear clear, clinically grounded discussions designed for nurse anesthesia residents and CRNAs who want to feel more confident in complex pharmacology, physiology, and real-world anesthesia decision-making.Want more content like this? Become a member of our learning platform: http://atomicanesthesia.comIn this episode:Atomic Anesthesia platform 2.0 updates, including faster performance and new study features.Highlights from the World Congress of Nurse Anesthetists in BrisbaneOverview of International Federation of Nurse Anesthetists and global nurse anesthesia standards at IFNA.orgReflections on global anesthesia practice, patient safety, and international collaboration.

Crna Gora ulazi u jubilej između europskih ambicija i dubokih unutrašnjih podjela. Politički prostor ove vjerovatno buduće članice EU i dalje oblikuju identitetske tenzije i nasljeđe ere Mile Đukanovića? Na koji način tačno? Situaciju u zemlji dvadeset godina nakon referenduma analizira Maja Marić u razgovoru s Branislavom Radulovićem, predsjednikom udruženja pravnika Crne Gore. Kako se, uz koncert Ricky Martina, Podgorica sprema za proslavu nezavisnosti saznajemo od dopisnice Vesne Rajković. Von Maja Maric.

What does the future of CRNA education actually look like? In this episode of Airway Exchange, hosts Nickie and Greg sit down with Hallie Evans, DNP, CRNA, APRN, CNE, FAANA, to explore some of the biggest challenges and opportunities facing CRNA education today, including faculty shortages, mentorship, innovative teaching methods, competency-based learning, and the growing role of AI in healthcare education. Here's some of what you'll hear in this episode:

Hosted by David and Nycci Nellis. On today's show: · Regina McLinden , founder of RM Wellness in Georgetown – specializing in customized massage therapy, manual lymphatic drainage, and showcasing local art; · Take a deep breath – because Tanya Saunders is here. Tanya is a Certified Registered Nurse Anesthetist – a CRNA - a nervous system educator, and trauma-informed breathwork facilitator specializing in stress physiology, emotional regulation, and human behavior. Her work focuses on helping high-performing humans understand how chronic stress, the multitasking culture, and nervous system patterns shape performance, relationships, decision-making and overall well-being; · It's all about the skin! Dr. Arleen Lamba is founder and CEO of GLO30, a modern skincare studio revolutionizing skincare with AI-personalized, professional-grade treatments; · Eva Cranford is a personal training manager with Equinox Wisconsin Avenue in Washington. Eva's her with the 411 on Equinox's ARC program - comprehensive personal training, nutrition coaching, & regeneration programming, focused on the whole & total health of women; · Normally we have cocktails/wine/beer/spirits – today we're going healthy with Greg Rozeboom and Fruitive. In 2012, Greg founded Fruitive, a 100% plant-based, organic fast-casual concept focused on fresh, made-from-scratch food and everyday wellness. We'll have taste and talk of Fruitive throughout the show.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosted by David and Nycci Nellis. On today's show: · Regina McLinden , founder of RM Wellness in Georgetown – specializing in customized massage therapy, manual lymphatic drainage, and showcasing local art; · Take a deep breath – because Tanya Saunders is here. Tanya is a Certified Registered Nurse Anesthetist – a CRNA - a nervous system educator, and trauma-informed breathwork facilitator specializing in stress physiology, emotional regulation, and human behavior. Her work focuses on helping high-performing humans understand how chronic stress, the multitasking culture, and nervous system patterns shape performance, relationships, decision-making and overall well-being; · It's all about the skin! Dr. Arleen Lamba is founder and CEO of GLO30, a modern skincare studio revolutionizing skincare with AI-personalized, professional-grade treatments; · Eva Cranford is a personal training manager with Equinox Wisconsin Avenue in Washington. Eva's her with the 411 on Equinox's ARC program - comprehensive personal training, nutrition coaching, & regeneration programming, focused on the whole & total health of women; · Normally we have cocktails/wine/beer/spirits – today we're going healthy with Greg Rozeboom and Fruitive. In 2012, Greg founded Fruitive, a 100% plant-based, organic fast-casual concept focused on fresh, made-from-scratch food and everyday wellness. We'll have taste and talk of Fruitive throughout the show.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Spencer Jones, Founder of XO Medtech and MedtechVendors.com, shares how frontline nursing experiences led him to patent vascular access innovations and ultimately take devices from idea to FDA clearance and product launch. Spencer walks through learning business fundamentals through accelerators, raising early funding, and building sales and distribution networks, then explains why launching a digital-first, AI-native ecosystem has enabled faster, leaner execution than traditional medtech pathways. Spencer also discusses leadership, clear communication, and why AI adoption is essential to accelerate and de-risk early-stage medtech.  Guest links: https://www.linkedin.com/in/medtech-innovation/ | www.xomedtech.com | https://medtechvendors.com/  Charity supported: Polaris Project Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com.  PRODUCTION CREDITS Host & Editor: Lindsey Dinneen Producer: Velentium Medical   EPISODE TRANSCRIPT Episode 080 - Spencer Jones [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello, and welcome back to another episode of The Leading Difference podcast. I'm your host Lindsey, and today I'm delighted to welcome to the show Spencer Jones. Spencer is the founder at XO Medtech and MedTechvendors.com. He is an RN, MedTech entrepreneur with 12 years of med device leadership. He's a two time med device CEO with 10 plus patents under his belt and has taken devices from idea to FDA clearance and product launch. Spencer has built sales and distribution networks, led product development teams, and raised over 10 million in VC and Angel Capital. Spencer founded XO MedTech in 2024 to create a digital first medtech ecosystem, deploy AI native tools for medtech operators through medtechvendors.com and cultivate the next generation of medtech innovators. All right, Spencer, welcome to the podcast. Thanks for being here. [00:01:43] Spencer Jones: Thank you for having me, Lindsey. I'm very, very excited to be here. Like it's, it's always more fun to be a guest than it is to host the pod, so absolutely thrilled to be a guest on the pod. Thank you for having me. [00:01:54] Lindsey Dinneen: Of course. Absolutely. Well, yeah, let's just, if you won't, don't mind just sharing a little bit about yourself, your background and what led you to medtech. [00:02:04] Spencer Jones: Yeah. Born and raised in Arkansas. I've lived, I traveled a ton and lived in Memphis and whatnot, but grew up in a healthcare household. Dad did anesthesia for, what was it, 36 years or something at the same place. So I thought I was gonna be a CRNA, like actually started pre-med. Took chemistry my freshman year while I was, you know, it was just, I got a C and I was like, maybe, maybe med school's not for me. But but anyways, did the nursing school thing, got out, started working, pretty quickly, knew if you've ever spent any amount of time in frontline healthcare, you just kind of get, it's like a barrage of things that suck. It's just, especially nursing, the devices you're using are commoditized. Like just the workflows are bad. You know, people, it's, healthcare is very broken. Every, it's no secret. Everybody says that. Everybody knows that. So anyways, I noticed pretty quickly that hey, like why isn't this better? Why can't this be like this? And, you know, kind of had that mindset. And before I could even go through like critical care enough to apply to a CRNA school, ended up patenting some devices in the vascular access space. Really leveraged accelerator programs and the entrepreneurial support organizations that were in my area, in my region to, I call it that get that dirt money, which is like the before the seed, you know, your pre kind of, your pre-seed /seed you know, before the pre-seed money. And, and also like the business training, right? Like I wasn't formally trained on business stuff like that. So did that. Did the venture capital hamster wheel a little bit, took a, you know, device through class two de novo clearance. Was doing ride-alongs training, sales reps, doing marketing stuff, you know, managing our ip, managing clinical you know, 300 patient RCT that we had to do in the middle of COVID, launched the product and then past couple years, I left, left that company in 2022. Products still on the market and they got, you know, clearance in, in Europe now and et cetera, et cetera. But just been working more in laparoscopic spine or laparoscopic surgery orthopedic spine and then doing some like consulting projects and, and things like that. And then yeah, XO Medtech and Medtech Vendors that's been. You know, for the past two years, like a big focus. And I know we're gonna talk more about that, but yeah. So it's just been, it's been a great journey. Medtech is one of my --I love it and hate it at the same time, but I wouldn't wanna be doing anything else, frankly. So. [00:04:17] Lindsey Dinneen: Awesome. That's a great intro. Okay. You were, I really, I enjoyed how you sort of went straight from okay, so, so "I, you know, started the career, started in the industry, and then I, I, you know, got a bunch of patents." What were the ideas for the patents? Where did those come from? If we could just go back, how did that, what was that inspiration like? [00:04:39] Spencer Jones: Yeah. So I was night shift, med-surg, big, pretty big hospital in Little Rock. It was like one of the, one of the bigger ones in Little Rock, St. Vincent's, which is like CHI, St. Vincent, et cetera. And like one of my patients --well the, the very first one was a dual lumen peripheral IV. A patient has a peripheral IV in, I need to get a blood draw. They're like, "Go stick his other arm." I'm like, "Why can't we get it out of his, you know, IV that's in his, that's in his forearm?" And, and they were like, "Well, you, you know, you don't want to contaminate, you know, the thing." And I was like, "Oh, okay. That kind of makes sense." And I was like, well, PICC lines have two lumens. So you know, I was like, why couldn't, you know, why couldn't we just have a second lumen on, you know? And I was like, do those exist? And they didn't really exist. There was kind of one that existed, but it was more of like a longer extended dwell peripheral and you know, you kind of needed ultrasound to place it. You didn't really place, you know, normal nurses on the floor weren't gonna place it. And so I kind of, that one was just sheer-- I experienced something that I was like, "Dude, you're kidding me. There's gotta be a better way to do this." You know what I mean? And you know, kind of similar approach in that one. We, you know, that was the very first one so I was like doing these drawings on note cards and then like meeting with a patent attorney and I was like, did that provisional filing and wrote the patent myself and the claims and all this stuff. And the guy thought I was like, just " Okay, yeah, I'll, I'll file the provisional for you, bro, whatever." Filed the provisional, you know, ended up like going to a different attorney 'cause that guy was kind of just not taking me seriously. And so, ended up going to a different person, filed a non-pro provisional, started raising all this money, and that original attorney reached out later, was like, "Oh, so glad, glad to see blah, blah, blah." I was like, "Yeah, yeah, whatever." But then the second one, I, which was Safe Break Vascular, had the, it's kind of similar. Patient was like, had patients pulling out their IVs, pulling out lines, you know, and it's a million things. It's, it's walkie talkie, so like Alzheimer's, dementia, memory care type stuff. You, it's TBIs, it's agitation, sundowners. It's, you're coming off medication, you're drowsy, you forget, you're hooked up. You need to go to the bathroom. You trip on it. The nurse trips on the tubing. There's like a million reasons how, you know. Where mechanical force can get applied to an IV line. And same thing, I was just like, man, like this, it, it feels holding on for dear life is like the wrong approach because skin is only so strong. You get skin tears. Adhesives, you only want them to be so, you know, so, so strong. And it just, you know, it, wrapping it up, then you can't assess the site, you can get infiltration. So it didn't feel like any of the options we had were great. That one, I started to do patent research literally on the floor at the hospital. Like that night. I was like, I, 'cause I knew enough then found someone that had patented it. Like same exact concept. It was a nurse. And design was bad. Like the design, it had springs in it and it was just like not manufacturable and not a good design, but there were like conceptually it was like spot on. And then there were some elements of it that I was like, this would be very useful to have if I was gonna like actually do this. So me and somebody I'd met, and in accelerator program, we bought the patent from 'em for 20 grand which was a steal of a deal. It was like 10K up front, 10K after 18 months. And yeah. And then we turned around and raised a, you know, million dollar seed round within like, within nine months after acquiring the patent, got into an accelerator, ZeroTo510, shout out to them. But acquired the patent in February. Got it, or March, got into ZeroTo510, April. Went there in May, closed our seed round of a million in December, so it was like a nine month, yeah, ordeal. [00:08:03] Lindsey Dinneen: Wow. That's okay. That's awesome. I love the story. I love the fact that it was from boots on the ground going, "Okay, I see this problem. There's gotta be a better solution." That's super cool. So. All right, so you have these patents, you're going and you're working with accelerators. Can you tell us a little bit about what that experience was like, especially since you mentioned, you know, you didn't necessarily have the business background, so there was, there was probably a bit of a learning curve to that whole, you know, how do you get your idea from your, your note card drawing to commercialization. So I'd just love to hear about your experience. [00:08:35] Spencer Jones: Yeah. The, so I did one accelerator before ZeroTo510. It, I basically did two within about a year, a year of each other. It was like back to back to back. But the first one I did, it was industry agnostic. So it was just a lot of like mentorship and lean canvas startup methodology kind of business practice stuff like accounting 101, you know, building financial forecasts and models and like all of that stuff. So I really learned a ton about kind of just non device specific stuff there. Obviously I was learning a ton about device stuff along the way, but then once I got to ZeroTo510, that's when things kind of like really, you know-- and I had, I had won, I won that first accelerator. It was like a competition, and so I had 150K. And I was like, "Oh wow. So maybe, maybe this is gonna be a career path," 'cause I was still working full-time as a nurse and then I got into the second one. ZeroTo510 was amazing. Allan Daisley was running it. James Bell was like the co-director, I think, and it was like bootcamp. It was like, you know, 8:00 AM to 5:00 PM. It was like sessions and mentor hours and office hours and " Alright, we're done with that. You guys work on this for an hour and a half, we're gonna come back and talk about like the finished product and you better have it done." You know what I mean? And it was every day. I lived up at this building. It was amazing sponge mode. You know, it was one of those environments where you're just like constantly soaking it in and learning and learning and like you can feel your brain expanding like every day. You know, you wake up excited. And that one was amazing. Met a ton of people that I still work with today. You know, met my co-founder at XO Medtech. Met him at that accelerator. But yeah, it was just, that one was amazing. I was like, life changing. Came back from that and I was like, "This is what I was meant to do." I felt like I you know, found my calling. And so, yeah, shout out to the people there that you know, we're a part of that. [00:10:20] Lindsey Dinneen: Love it. Excellent. So, okay, so you found your co-founder for XO Medtech, and this is great because I wanted to dive into that. So, so you've, you've now successfully taken like several products to market and of course you have a lot of other great industry experience. What was, how was it different starting XO Medtech and Medtech Vendors than perhaps other things that you'd done in the past? [00:10:47] Spencer Jones: Yeah. You know, I'm gonna say it was way easier just to be honest. I mean, I mean, you know, I think we, we were doing a lot. We started building XO Medtech in 2022, 2023, and at that time a lot of it was like, it was really focused on the community and the training platform and the resources and kind of all the videos and things that we put in there. Which I still like to this day, will stand on it, that like there, if you're an early stage innovator and you're, you wanna like kind of internally like level yourself up, right? There's no better place than like XO Medtech and the training and inside there to do that, right? But, but yeah, it was we started doing it at a time when AI was starting to become, like Chat GBT, what was it, four was coming out or whatever. So we started it kind of before the wave and then as we were continuing to build it in like 2023 which was like the meat of us building it. It was like kind of starting to become more of a thing, but we still weren't really using it that much. But then as we really went into kind of like launch and growth mode in 2024, it was just like a huge tailwind and like being able and, and it continues to be. But like not having to raise, you know, three, four, $5 million to get a business off the ground and to get to a point where you can start selling something is just incredible. I mean, like we are, we are so agile and can move so quickly and, you know, we don't have any investors. We don't want any investors. So like our speed at which we can move is unbelievable. And coming from somewhere where it's " Oh, you wanna put out something for marketing? Route it through the quality management system and like maybe it goes out in two weeks." You know, we can go from like idea to feature in a week. You know what I mean, you know, let alone like idea to like press release, right? That's 10 minutes if we want to be, right? So really it's just, it's a lot easier and this takes nothing away. There's some incredibly rewarding parts of kind of my, like my medtech journey and stuff like that, like the day we got FDA clearance and, and X, Y, and z whatever date, you know, first sale and getting our first GPO contract. But it's, it's definitely more I would say day to day, just like the exhilarating agility, excitement type stuff that you like, don't really get with with me. And I'm not, I'm not taking anything away from, I'm still a medtech person through and through and I'm sure at some at some point I'll you know, do another device. We're developing another device at Lapovations, so, in combo spine. So my hands are still in it, but I love, love, love what we do at XO Medtech. It's so much fun. [00:13:11] Lindsey Dinneen: Awesome. Well, I love hearing that. So tell us a little bit about both XO Medtech and Medtech Vendors and yeah, their, their focuses. [00:13:21] Spencer Jones: Yeah. So I think, you know, like I said, we started XO Medtech and it's, it's a online community. So think like Skool, like S-K-O-O-L School or Circle, or there's some other Mighty Networks, like one of the-- we use Circle-- but you know, it's whether you're ideation or just like curious about medtech all the way through like series A really, you know, we've got, you know, there's community feed, people are posting. I mean, we posted you know, Project Medtech, you know, event stuff, discounts a lot of exclusive stuff where, I think we added, it was like three or $4,000 worth of discounts. Like just for being like once you join XO Medtech. But then there's that primary feed people, it's like a massive exchange of value and it's it's not like LinkedIn. There's no promotion. Like we base, we will take your post down if you're like nakedly promoting your own stuff or your services, whatever. The whole point of it is to be massive exchange of value. So you know, "Hey, we did some like really cool testing, ETO sterilization testing on coil tubing to see how it retained its memory. Here's what we found, your pictures," you know what I mean? Just stuff like that where it's like kind of giving people behind the, behind the curtain peaks at your own organizations or that kind of, those, those moments of alpha, those nuggets that you've found and just sharing it so you can have you know, and they're doing the same and everybody's better for it. But then we have a training course and then some other like mini courses, probably a couple dozen downloadable resources. So these are like, you know, prebuilt, proformas, budget forecasts, you know, IP stuff, due diligence type stuff, like stuff to help you with, get your data room beef, you know, beefed up and looking good. And we do videos. There's some live events every now and then. So, so that was very focused on the founder side, you know what I mean, like the entrepreneur side. We, you know, my co-founder used to run a med device, venture studio, so like doing like business engineering, business development, engineering, you know, kind of market related stuff for like early stage, largely like clinician and inventors and stuff like that. He used to run a, a, a group that did that. And we knew we wanted to kind of start to do more offerings that kind of for that side of the table, like the CDMO contract manufacturer design and development group side of the table. So we launched, we started building MedTechVendors.com and launched it in 2025, February, 2025. And then did kinda a relaunch with adding some like agentic AI features in I think at the end of the summer last year. But it, but at its core, I always say this analogy, it's like Angie's List, right? You know, Angie's List, what do they do? Well, it connects people with local pros. Allows them to like, evaluate, engage them really easily, you know, get, get their stuff done quickly from trusted people. You know what I mean? So we have the same approach. We help device teams, and that could be device teams at large, medium, small, or startup organizations or tech transfer offices, whoever we help those device teams find, evaluate, and engage contract manufacturers, CDMOs testing facilities, design and development groups, one man band engineers, whatever through the platform. We have an an ag agentic AI chat. So like it'll ask you questions about your device. It'll start recommending, "Hey, do you need this? Do you need these types of services? Are you looking for this type of vendor? This type of vendor?" It pre-populates forms. It generates matches for you. You can review each vendor's profile, one click get email intros or request quotes, and we're adding some some really cool additional features around some different like skills that you can run. So, think like a reimbursement skill or market a, you know, different predicate device selection skill, whatever. And so those are all gonna be like linked up to the to this kind of AI agent. I don't wanna say too much 'cause we're still building it. I'm like really excited about, but there's other things that we're adding to it. The ability to do quote, visualization you know, and trying to make it kind of a, you know, a home away from home, a hub where you can track execution, get things done, engage vendors, and kind of evolve it more laterally in kind of the lifecycle journey. Not just " Hey, I'm looking for a vendor," 'cause that's a very acute point in time in a, you know, in a person's journey. But trying to expand it out to say the period of time when you're doing X and Y and Z and looking for a vendor so we can get some really was sticky, more sticky use and add more value. So, that was that. And we've started really focusing on some more like intimate, I would say, engagements with CDMOs contract manufacturers focused on giving their sales and marketing teams massive, massive leverage using AI and ai, AI native tools. [00:17:35] Lindsey Dinneen: Awesome. That's really cool. Yeah. Okay, so going back a little bit to the, to XO Medtech, I know you know you, you mentioned that there's a lot of resources available, but one of the things that I think is super cool, and I would love if you just share a little bit more about this, is you have a course that-- i don't remember the name off the top of my head-- but it's basically sort of Medtech Innovation 101. It's, I think... [00:18:00] Spencer Jones: Yeah, The Playbook. [00:18:00] Lindsey Dinneen: Call it like-- The Playbook! And you call it like the MBA for somebody who needs to learn. So can you just share the value of that and sort of what, what made you go, "Okay. I have, you know, the expertise in all these different areas enough to be able to share the journey from start to finish." [00:18:19] Spencer Jones: Yeah, absolutely. I think like the, the value there partially comes-- I mean, I think speaking about the value, you gotta speak about kind of like why there was a gap there, like how it, why it didn't exist, whatever. There's just a lot of really bad content in medtech. You know, there's a lot of stuff that reads I mean, there's guidance documents, you know, ISO and this and that. Like those are tough reads, right? And then, you know, the, the content around " "here's how you really fundamentally apply these guidance documents and here's how all this fits together." And it just felt like everything was I don't know what the opposite of like inside baseball is, right? Like that kind of " Hey, here's what you really need to know." Whatever the opposite of that is, is how medtech content felt like to me everywhere. It was just like polished press releases, really, like consulting speak. You know, "You gotta be strategic with your analysis." It's okay "You know, you know, you gotta find your champions." "How do I find them? What do I tell them? You know, how do I engage them?" So it was just, that was the big gap. So I think the value, what we tried to do with The Playbook was, you know, give, like I said, pre-seed all the way through Series A, the right information, like the right depth, on the right topics in the right order with the right assets, so resources, downloads, all that stuff along the way so that you can go cradle to grave on this, basically be a novice, or we've had people that have launched products and gone through it and they were like, "Holy crap, I wish I would've had this five years ago." But the whole idea is to basically not make you a supreme expert on any one of those topics. There's 46 different lessons, 47, and like you can get through each one in probably 20 minutes, right, 15 minutes. But not to make you an expert on each individual topic, but to give you like a dangerous level of information on any one, and then make you able to dive deeper on any of them, you know, very quickly and easily. So like when you meet with your, you know, a regulatory consultant or an IP attorney, or go down the list, you are not, they're not saying words you don't know for the most part. You're not paying them $300 an hour or $500 an hour to educate you on definitions and concepts. Right? You're, you're applying principles and evaluating strategy versus " What's that again? Like, how does this, what's the timeline for that?" 'Cause that you know, that's just not good for anybody. You know, so, so that, that's kinda the main, the main value prop thrust of it. And I just, I frankly didn't think it existed, but proof's in the pudding. Like we've sold it to accelerator programs, we've sold it to hospital, you know, innovation departments. We've sold it to incubators, like trade associations that have like their like kind of innovation arms. It works. Like when people do it, it works. It's funny-- we can talk about this too-- but like the, you can lead a horse to water thing. It's funny how many people say they want to be entrepreneurs and say they wanna be innovators and really they just want to just yap. And they don't actually wanna put the time in. I'm telling you, it's like crazy how many, you know, fake entrepreneurs there are out there. But it's okay. It's okay. You know, like there has to be, I think there needs to be some cleaving or weaning or calving of the herd to some degree because we've got, I don't know, and maybe we need to develop 'em more, but it's, it is frustrating seeing it firsthand when it's like "You have a really cool device, but you are so uninvestible and you have no interest in being coachable that it just hurts me." [00:21:30] Lindsey Dinneen: Oh yeah, absolutely. No, I love that you've done that resource and yes, super excited to see hopefully a lot of innovation actually happen and be successful as a result of that. So with, you know, okay, so you have, you have this community now and I'm wondering if there are any moments that kind of stand out to you, maybe as you've built the company, also Medtech Vendors that kind of enforce, "Wow, I am, I am in the right place at the right time." [00:22:00] Spencer Jones: You know, I definitely-- you know, it's, it's, it's really, there's not, I would say, any huge singular moments. I mean, we've had people like get business from coming on the XO Medtech podcast. You know, we've had people meet new clients, new strategic partners type stuff, like in the XO Medtech community. I mean, I've made a ton of friends in the XO Medtech community, people that I talk to you know, every, every week or two you know, Brad Shirley, I'll mention him. He's fantastic. And like I've learned from him, he's learned from me. We've both learned stuff from the community. I, I, I really do think it's though, it's like it's, you know, those-- whether it's a LinkedIn DM or you know, somebody messaging me in XO and they're like, "Hey, I just went through this lesson. It was like, so good. You know, blah, blah, blah." And I think those little things honestly like power me, power me up, give me juice, give me energy. You know, and, and like reading, we, we did a ton of, I mean we probably got 30 people that did kind of like a pre- and post- assessment and they gave their feedback on The Playbook so we could refine it like as we were, you know, after launch and all that stuff 'cause we're constantly trying to improve it. And have reading the testimonials and people just being like, yeah, like "This is, this is killer." People that are brand new, people that have been in the industry for 20 years that went through it. I think so, I think, I think it's kinda like a myriad of those things. I would say some of the stuff on-- and that's on the XO Medtech -- I think some of the stuff on the Medtech Vendor side and what we're doing with, you know, kind of campaigns and the tools that we're developing and the work that we're doing there, like we are fully an AI native organization. Like it, like we, it there is just not at all like a significant amount of people in medtech using AI to like actually do not in their products. I don't care about that. Like I'm talking about like in their day-to-day operations and, and whatnot and like we're trying to change that. And so like in that respect, like we will come out with things, you know, release features, release products, build custom tools for CDMOs and you know, the looks on their faces and like how amazed that they are at X, Y, and Z. And sometimes it's like stuff where it's hey, I'm like building them a just showing them how to do something with not even a tool that we built and like they're blown away. And anyways, all of that stuff, I feel like, man, like this is where I'm supposed to be because like. We, we've gotta make MedTech a more attractive investment opportunity. We've gotta compress the development cycles and the cost to develop and the time to develop and get things to market. You know, and I look at AI drug discovery for the pharma world as like a huge way that that's happening. But we have to have that similar type of like, when you to engage with this, it will be good for our ecosystem and industry as a whole, becoming more investible, becoming more cash efficient and all that stuff because you've seen other sectors, you know, software is taking money from early stage medtech, like nobody's business. You know, people are investing AI and you know, I just looked at the annual report from like HSBC, the Venture Report, and like me, early stage medtech funding continues to be down. You know what I mean? So we just gotta do something like, I, I feel like it's an existential, it's an existential issue for early stage medtech to get better at being scrappy and using AI. [00:25:03] Lindsey Dinneen: And there's so much opportunity there. Yeah, I love that you're helping to promote that. So you've gotten to lead a number of different companies now and through very challenging milestones. And so I'm curious, how has your own leadership philosophy developed over the course of your career so far? [00:25:24] Spencer Jones: Oh, what a good question. You know, I, I hate to say this, but I've almost gotten more cynical, you know. [00:25:30] Lindsey Dinneen: Okay. [00:25:31] Spencer Jones: Well, and it, it's, it's like I try to be very protective of my time and like protective of the time of the people that I work with, right. You know, and that doesn't mean I'm not willing to like go the extra mile and whatnot, but I think it's about respecting people's time. Right? And, and you know, I think honestly my leadership philosophy, I think a lot of it revolves around just like incredibly clear communication and like staying above the fray. No riff-raff, just just executing and moving fast and like keeping expectations really high, because I feel like when you've got complacency, you know, at the top, it just, it like doubles every rung of the ladder lower that you go in the org chart or whatever. You know, so I think like pace, you know, pace and hyper clear communication, like no subversive or passive aggressive or anything. It's just like straight up, like I'll just exactly tell you if I wasn't happy with something or whatever, but I just, I don't know, like I feel, I feel like you know, leadership style too, like I think, I think it, so much of it boils down to communication for me. It's just like really, really clearly communicating and like making sure that people understand what good work looks like and what a, them doing a good job looks like, and where... Yeah, I think, I think being clear about expectations, really clearly communicating those expectations around like work product, what it should look like, how fast it should get done, how many updates I need, or how many questions I expect to get as you're doing this, what resources I expect you to expend and explore before you come to me with something you could Google. Like all of that stuff, but honestly, I, it, it's kind of a tough question thinking in like the more immediate past, just because I feel like there's been such like, almost like a flattening of org charts, frankly, with the way that we're using technology and AI these days where I feel like in the companies I'm operating in right now, like it's mainly just principles and like lower level stuff, like we're either delegating to AI agents or delegating to like VAs that are in a different country or something, you know what I mean? And, and so there's just been a big flattening. You know, seven years ago, six years ago, I was managing, you know, new grads outta college, two or three at a time, and, you know, having to like, have these kind of like, you know, like brotherly, you know, like talks with, you know, these types of things, " Hey, like you really gotta do this" and like coaching and stuff like that, i, you know, there's a, we have to have that stuff. I'm just not in, in organization and honestly, the organizations I'm in right now in startup world I just feel I don't know. Like I, I feel like we're, I haven't seen that and I, I know a lot of organizations that are small and nimble and whatever, and I feel like the org charts are getting real flat in terms of like people that are getting managed, you know, it's a lot of agents getting managed, frankly. [00:28:21] Lindsey Dinneen: Yeah. Yeah, yeah. Interesting. Yeah, that, that's a really interesting insight too. But I really do think that to your point of coaching and mentorship and how much of a difference that makes, but especially, I was just on this conversation earlier today of the critical importance I feel that there is about establishing expectations across the board, whether it's your clients, your employees, your coworkers, just making sure that everybody's on the same page is such a critical aspect of, of setting yourself up for success. So yeah, I love that you touched on that 'cause like I said, literally earlier today. [00:29:00] Spencer Jones: Yeah. And, and can I, can I, quick aside here. It's, it's on topic, but before we move on, I mean, I, I'm not the first person to think this or say this, but I'll, I'll die on this hill. The more you use AI when, when you're using it the right way, right, the better leader and better specifically, the better communicator you'll become, right? Why? So much of interpersonal office drama, bad management, bad leadership is like what we talked about, right? It's poor communication. It's expecting people assumed something or had knowledge they didn't, right? It's not letting them know what you really wanted, what good work looks like, all that stuff. This is all context engineering, right, which is just a similar to prompt engineering, but context engineering is kind of the other more important piece these days with AI. What do I mean by that? Like I'm gonna give a prompt to a chat. Is it in just like a virgin chat or is it in a project? What context, what documents, skills, reference templates, et cetera, access to code bases does that project have, right? What am I telling it to do? How am I breaking that down? How am I, you know, big, high level goal? What do I want it to do? What does the output need to look like? How deep do I want it to go? Right? Like, how many questions I say, "Ask me like five or six questions" when I'm prompting, right, if I want that, right? Give, so giving the other person right in that space to say " What questions do you have?" Right? The, the, the best people at context engineering and leveraging AI in that way end up becoming more, better and better and better communicators because it's-- I mean, yes, you're talking to a machine, but at the same way, like those principles a hundred percent apply to good professional communication. So I'll die on that hill. There's a lot of people that are like brain rott using AI. It's " what's the weather today?" And you know, "how many calories does mayonnaise have?" And those people are not, you know, they're, they're not improving their leadership communication by using app, but the people actually doing it right a hundred percent are, [00:30:52] Lindsey Dinneen: Yes, I could not agree more. I think that is one of the coolest things that AI has taught me personally is-- to your point, to be a better communicator, to be clearer with the way that I communicate, to avoid assumptions that the other person, say, knows what I'm talking about or, or does have the context behind why I asked the question the way I did, or all those kinds of things. So I, I could not agree with you more. Yeah. And it's exciting to see how it continues to evolve. Okay. [00:31:22] Spencer Jones: Yeah. And why, real quick, why, like the AI models, especially with the reasoning models and stuff, Opus 4.6, all this stuff, telling them why they're doing something and why doing it, doing a certain task within that project flow is important is proving to be more effective than telling them how. And I think that's something where, you know, you tell someone what to do, they may do it, but if you tell them and make them believe why it's important, they do it that way, they're really gonna do it that way. [00:31:49] Lindsey Dinneen: Yeah. Love that so much. Okay. All right, so pivoting the conversation a little bit, just for fun. Imagine that you were to be offered a million dollars to teach a masterclass on anything you want, could be within your industry, but doesn't have to be. What would you choose to teach? [00:32:05] Spencer Jones: Does this, assume-- I have a question. Does this assume that I'm already I'm already capable and you know, have enough expertise to actually teach this class? Or is it like I choose this topic, I'm now an expert in that and I get to teach it? [00:32:19] Lindsey Dinneen: I like, I like I like both options, but I'm gonna go with option B because you have a million dollars to play with, right, so you could build up the expertise. Yeah. [00:32:29] Spencer Jones: You know, I would still say like building AI tools, AI agent systems, you know, skills and subagents and these flows and, and really tactically executing that for medtech. And that that goes from founder, you know, innovator to service provider, reg, quality ,reimbursement, like all the way up through sales and marketing and then like CDMO teams, you know, doing contract manufacturing, doing this. Like I, I just, I'm so passionate about it and I, I just see that there's so much untapped opportunity that that is the thing I think, and, and like we, we are doing that not a masterclass, but like we are working with groups to do some of that. But, I just, it's just so, so, so, so much opportunity to do it. And I think there's like weird structural reasons why it's not being adopted the same, you know, at the same clip it is in other industries. But you know, medtech's very rules-based game. You know, you've got your guidance docs, you've got your predicate devices, you've got your clinical trial protocols, you've got your stats analysis. You got your, you know, X, Y, Z hospitals get paid a certain way. Like lots of formulas, lots of reference material, lots of guidance docs. You know, it's very kind of rules and order based system in a lot of ways. And biology has its own kind of, prescriptive way that things happen, right? So I just feel like it's so primed for it. And anyways, I, I just, I wanna see it adopted more so we can see like what's happening with software now, where, you know, the cost to build and, you know, produce and get software to market has com has almost collapsed, but compressed to, you know, from like months, maybe years to, you know, days and weeks and, you know, you got a $200, 250 bucks worth of like software subscriptions, Claude this, that, the other, you can get it done in a week if you, you know, two weeks if you put your mind to [00:34:21] Lindsey Dinneen: Yeah. Yeah. No, that would be an incredible masterclass. I like it. All right. And then how do you wish to be remembered after you leave this world? [00:34:30] Spencer Jones: Oof. God, what a good question, Lindsey. You know, I hope to be remembered at all. [00:34:35] Lindsey Dinneen: Yeah. [00:34:36] Spencer Jones: You know, 'cause I, I'm definitely one of those people that's " nobody cares, nobody's thinking about you." You know, you may have, I, I mean, I think there's like some healthy main character syndrome that people can have that gives 'em confidence, but at the end of the day, no one cares. They're just, everyone's thinking about themselves. But if I am remembered, which I hope to be I wanna be viewed as like someone that was, I'd say, loved their family was a good dad, good husband. I would say brought people joy, was like fun to be around, but like from a interested in other people sense, you know, you know, genuinely cared about people. But I would say that on the professional side, like somebody that you know, would like consistently just delivered an absurd amount of value whether it was, you know, running a business or coaching and developing people at a company or working on behalf of clients or trying to make a positive change. I would say impactful and valuable, you know, with the work that I'm doing. That's, that's, that's how I wanna be remembered. I mean, we don't have big, I don't wanna be a unicorn billion dollar company. No, we have no desire to do that. We don't even have a, a desire to get acquired at any point. We're not raising money, you know, we've, we've deliberately chosen to bootstrap it. You know, we frankly just wanna employ really awesome smart people that we work with, you know, pay everybody well. And like I said, add a absurd amount of value you know, and joy to the people and the clients that we work with and like work at the company with, you know what I mean? [00:36:05] Lindsey Dinneen: Yeah. Yeah, that's a absolutely wonderful legacy to aspire to. I love it. All right. And then final question. What is one thing that makes you smile every time you see or think about it? [00:36:19] Spencer Jones: Oh, I gotta be, I've got a 1-year-old kid. Banks. Banks Austin Jones. So it's gotta be him, and my wife of course. One thing that makes me smile though, every time I see it, oh... you know, I am, I'll cry at a good TikTok, so I'm so I guess that's like a form of smiling, you know? But I'm a pretty big softie, honestly. You know, this is gonna sound weird, but it's kind of those moments where you know, people usually strangers and usually people that don't look like each other, just show humanity to each other. And that could be like holding a door open for somebody. It could be small things, you know what I mean? But I really love seeing those moments and capturing them like candidly, you know? Just you know, oh, I was in a restaurant, I saw this thing happen. You know? I really love that these days. [00:37:09] Lindsey Dinneen: Yeah. Yeah. We all need more of that these days too, so, yeah. Love it. Alright, well, Spencer, this has been a, a fantastic conversation. I really appreciate you and your time today. I love what you're building in the medtech industry and cultivating community and resources and providing value. So just thank you for everything you're doing to change lives for a better world. [00:37:34] Spencer Jones: Thank you. Can I ask you a question? I feel like you were so good, like with the questions and kind coming on the back of like my responses, but I have a question for you like what? You know, what about the medtech space, like most excites you? It can be a specific technology, it can be a specific, you know, company doing something. It can be anything, but what's most exciting to you, kind of looking at 2026 and, you know, kind of in the realm of medtech broadly. [00:38:00] Lindsey Dinneen: Yeah. Oh, I love that question. So I love this industry in general, but there, there's something really special about the energy of being around people who truly care about making a difference. Part of the reason I started The Leading Difference was because I, when I first joined, had sort of noticed this sort stigma from people from the outside who weren't very familiar with the innovation, what it takes to get from, you know, drawing to commercialization. Just didn't, just didn't know. And there was this stigma that people were here just for the money. And then I started meeting all of these incredible change makers who they had personal stories of what they were seeing, or a family member was impacted. And I just loved the fact that there were so many cool people doing such cool things and getting to play a small role in that was the coolest thing in the world. So, you know, I, I say I happily stumbled into medtech five years ago and found my people and my happy place, haven't looked back. I love it. I love being around people who are genuinely trying to do good things in the world. And I hear about new and you know, new ideas every day, and I get excited probably almost equally about most of them because it's just cool to see. So I don't know. Does that answer your question? [00:39:29] Spencer Jones: No, it, it does. I mean, it, it really the, it all comes back to the patient at the end of the day. And I definitely, I, I feel like when people think of like medical device stuff, like their minds immediately go to like Stryker sales reps or something, you know what I'm saying? And there's just so much more to it than that. And there's one of my favorite things about medtech is like the personalities, you know, like you got your wacky, you got your wacky inventors and you know, you got your straight laced regulatory people. But when you get to know 'em, they're, they're absolutely hilarious. You know, you got your attorneys, you got your like, and I, every industry, every industry has their personalities. But I think medtech, you know, you got your beef head sales reps that are like posting " What's up guys? I'm here in the locker room in my scrubs" and like "Motivation Monday." You're like, "Oh my God." But it's just like all these personalities and you go to these conferences and you just see 50 of the same person, but they're each different, they have their own dreams and conflicts and ideas and whatever, but they're still like so in the same box in some ways. I think that's one of the funnier, like funnier things about medtech that just makes it quirky, you know? [00:40:30] Lindsey Dinneen: I love it. And I also love the amount of respect that I see shared amongst people of very, very different backgrounds and areas of expertise. And that was one of the things that made me fall in love with the industry too. I was like, I, for instance, you know, I'm in, I'm in marketing and business development, so I play a very small role in, in sharing about these devices. But people, the engineers that I work with and the consultants that I work with, and everybody in the ecosystem is always just " Wow, well, I can't do what you're doing. And so I think what you're doing is fantastic." And so there's just, there's this mutual respect that I think is super cool about being here too. So yeah, I'm a fan. [00:41:08] Spencer Jones: Yeah, I agree. I agree. We could, we could keep going for, for days... [00:41:12] Lindsey Dinneen: I know. [00:41:13] Spencer Jones: ...On this. I really, I know, I know we have to wrap it, but but yeah. Well, Lindsey, thank you for having me. Seriously, this was a blast. And you know, I'll just maybe like quick sign off plug or something here. If anybody that's listening to this is like interested in, leveraging AI, leveraging AI in medtech or for you personally or whatever, follow me on LinkedIn and post a lot of content about it. You know, talk about it a lot on the podcast. But then if you're, if you're on the founder side, if you're an innovator, like join XO Medtech. If you're on the CDMO side, if you're, you know, on a sales and marketing team, contract manufacturer, CDMO, even like signed development groups, that kind of stuff like, you are like, "We know we need to be using AI to better leverage X, Y, Z, or do this thing. We have all these, we have HubSpot and this thing and that thing, and none of it works together well and we've got too many tools." Whatever. Just hit me up. Let's have a conversation. We're doing some absolutely incredible things leveraging AI, giving these sales and marketing teams like crazy leverage. So yeah, just drop a dm. I'd love to talk to you. [00:42:08] Lindsey Dinneen: Awesome. Sounds good. And we are so honored to be making a donation on your behalf as a thank you for your time today to the Polaris Project, which is a non governmental organization that works to combat and prevent sex and labor trafficking in North America. So thank you for choosing that organization to support, and we wish you continued success as you work to change lives for a better world. Looking forward to seeing the future of all the good things that you're doing. All right. Bye. [00:42:41] Dan Purvis: The Leading Difference is brought to you by Velentium Medical. Velentium Medical is a full service CDMO, serving medtech clients worldwide to securely design, manufacture, and test class two and class three medical devices. Velentium Medical's four units include research and development-- pairing electronic and mechanical design, embedded firmware, mobile app development, and cloud systems with the human factor studies and systems engineering necessary to streamline medical device regulatory approval; contract manufacturing-- building medical products at the prototype, clinical, and commercial levels in the US, as well as in low cost regions in 1345 certified and FDA registered Class VII clean rooms; cybersecurity-- generating the 12 cybersecurity design artifacts required for FDA submission; and automated test systems, assuring that every device produced is exactly the same as the device that was approved. Visit VelentiumMedical.com to explore how we can work together to change lives for a better world.

What really matters when you move from being a student to stepping into your role as a CRNA? In this special crossover episode recorded at the AANA Mid-Year Assembly in Washington, D.C., Levi Davis interviews Airway Exchange hosts Nickie Damico, PhD, CRNA, CHSE, FAANA and Greg Collins, DNP, CRNA about advocacy, their role as educators, and the transition from resident to practicing CRNA. Mid-Year Assembly brings together CRNAs, residents, and nursing students to discuss important topics in the field of nurse anesthesia. It serves as a platform for networking, advocacy, and education, creating an atmosphere unlike any other.   Here's some of what we discuss in this episode:

The future of nurse anesthesiology leadership is on the ballot. In this special election edition of Beyond the Mask, you'll hear directly from every candidate running in the AANA Board of Directors, including candidates for Director, Treasurer, Vice President, and President-Elect. Each candidate shares their background, leadership experience, priorities, and vision for the future of the CRNA profession.

In this episode, we sit down with mentorship program participants Jon Casto, SRNA and Abigail Poss, SRNA, to find out what surprised them, what inspired them, and what they wish every future CRNA knew before attending AANA Mid-Year Assembly Stepping into a national conference for the first time can feel overwhelming but it can also be the moment everything clicks. You'll hear real experiences from residents navigating their first major professional event, how mentorship accelerates growth, and why getting involved sooner rather than later can open doors you didn't even know existed. Here's some of what you'll hear in this episode:

Airway management hasn't changed much in decades but that doesn't mean it can't be improved. As more procedures move into outpatient settings and deep sedation becomes more common, the need for better oxygen delivery and reliable monitoring has never been more important. That's where the Aeris Airways device comes in. It's a simple but powerful innovation designed to enhance standard airway tools, and we're diving into it with Cody Birch, CRNA and Airways Innovations Co-Founder, and Diana Lugo Imus, DNAP, CRNA. Here's some of what you'll hear in this episode:

Most SRNAs are focused on boards, clinicals, and landing their first job, but there's another side of the profession that can shape your salary, autonomy, and long-term career more than you realize. In this episode of Grade 1 View, AANA President Jeff Molter, MSN, MBA, CRNA, breaks down why advocacy is essential for everyone anesthesia professional. From student loan caps and full practice authority to Medicare reimbursement and access to care, Jeff helps us connect the dots between policy decisions and your future as a CRNA. You'll also get a behind-the-scenes look at Mid-Year Assembly, what actually happens on Capitol Hill, and how students can start getting involved earlier than ever before. Here's some of what we discuss in this episode:

In Part Two of our financial deep dive with Vinny Cagungun, we tackle four of the most-requested topics from our listeners: debt payoff strategy, the real financial differences between W2 and 1099, tax planning for high-income CRNAs, and how to find the right advisors for your team. Vinny, Cole, and Tanner share their personal journeys — including what they'd do differently in hindsight — and break down practical frameworks like the three-bucket tax system, the 1.3x rule for comparing W2 to 1099 offers, and often-overlooked strategies like QBI deductions and self-directed 401(k)s. Whether you're a new grad staring down six figures of student loans or an experienced CRNA looking to level up your financial game, this episode delivers actionable insight at every stage. As Vinny says, clarity comes from doing — so take it one step at a time and enjoy the journey.Support the showTo access all of our content, download the CORE Anesthesia App available here on the App Store and here on Google Play. Want to connect? Check out our instagram or email us at info@coreanesthesia.com 

For CRNA students, everything can come down to one moment: the board exam. But is it fair to measure years of training, clinical experience, and growth with a single high-stakes test? In this episode, Joshua Olson DNP, CRNA, CRNA educator, and co-creator of the Ollivate app, joins Erin and Louisa to discuss board prep and the use of artificial intelligence in CRNA education. Here's some of what you'll hear in this episode:

Welcome to the Atomic Anesthesia podcast hosted by CRNA professor Dr. Rhea Temmermand and Co-Founder Sachi Lord. On this show, you'll hear clear, clinically grounded discussions designed for nurse anesthesia residents and CRNAs who want to feel more confident in complex pharmacology, physiology, and real-world anesthesia decision-making.Want more content like this? Become a member of our learning platform.⚠️ SIGN UP FOR OUR FREE NEWSLETTER: [NEWSLETTER SIGN-UP]In this episode:Xenotransplantation is becoming clinically real, using genetic engineering to allow pig organs to function in humansRecent cases, including 271 days of pig kidney support, show potential as a bridge to human transplantKey challenges include chronic rejection, coagulation mismatch, and evolving immunosuppressionFor anesthesia, these patients bring unstable physiology, unpredictable hemodynamics, and increasing clinical relevance

On this edition of Inside the 1581, we're joined by Melissa Craft, dean of the University of Oklahoma Fran and Earl Ziegler College of Nursing, to discuss the role of clinical partners in shaping high quality nursing education and supporting student success. Craft shares how hospital partnerships enhance hands on learning, the challenges around clinical placements, and the importance of collaboration in meeting growing workforce demands. She also highlights the college's new CRNA program and how it will help strengthen the nursing pipeline and support healthcare systems across Oklahoma.www.insidethe1581.com

In a profession built on precision and high stakes, mistakes often come with shame, silence, and self-doubt. Failure is something every clinician experiences but almost no one talks about it. What if those moments are actually key to becoming a better provider? In this episode, Stephen Pilot, DNP, CRNA, APN explains how embracing failure can transform both clinical performance and personal growth. Here's some of what you'll hear in this episode:

What if learning could be both highly effective and a genuinely fun experience? In this episode, we explore an innovative approach to CRNA education that blends simulation, competition, and teamwork to create deeper engagement and better outcomes for students. AANA Chief Science & Practice Officer Shayne Hauglum, PhD, CRNA, APRN, joins the show to share how “Sim Wars” is reshaping the way students learn by focusing on communication, leadership, and team dynamics instead of just technical skills.  Here's some of what you'll hear in this episode:

Welcome to the Atomic Anesthesia podcast hosted by CRNA professor Dr. Rhea Temmermand and Co-Founder Sachi Lord. On this show, you'll hear clear, clinically grounded discussions designed for nurse anesthesia residents and CRNAs who want to feel more confident in complex pharmacology, physiology, and real-world anesthesia decision-making.Want more content like this? Become a member of our learning platform.⚠️ SIGN UP FOR OUR FREE NEWSLETTER: [NEWSLETTER SIGN-UP]In this episode:Why overthinking mistakes in CRNA school keeps you stuck instead of actually improvingThe difference between self-deprecation, reflection, and real growth (and why most students get this wrong)How small moments in sim and clinical turn into mental spirals and how to stop that cycleThree practical mindset shifts to stop replaying mistakes and actually move onReal clinical and classroom examples of mistakes and how to handle them without losing confidence

The Nurses Report on America Out Loud with Kimberly Overton, BSN, RN, BC-FMP – Nurse Kimberly Overton speaks with Debbie Heist Lambert and Bridget Belo, CRNA, exploring gadolinium toxicity, patient advocacy, and informed consent. Personal stories, emerging research, and censorship concerns reveal urgent calls for transparency, accountability, and restored trust between patients and providers...

GLP-1 medications like Ozempic and Wegovy have exploded in popularity for diabetes treatment and weight loss, but their rapid rise is creating new considerations for anesthesia providers. As more patients arrive for procedures while taking these medications, CRNAs and anesthesia teams must navigate evolving guidelines, potential aspiration risks, and uncertainty about perioperative management. In this episode, Amy Reed, Ph.D, CRNA returns to discuss the latest research and recommendations surrounding GLP-1 receptor agonists in anesthesia practice. Here's some of what you'll hear in this episode:

The transition from classroom to clinical rotations can be both exhilarating and nerve-wracking as expectations, personalities, and environments vary from day to day. Knowing what to expect can help ease the anxiety and better prepare you for this critical period of training.  Today, all of our hosts are back together to break down what clinicals actually look like from the student perspective. Here's some of what we discuss in this episode: ⏰ Show up early and prepared 

Welcome to the Atomic Anesthesia podcast hosted by CRNA professor Dr. Rhea Temmermand and Co-Founder Sachi Lord. On this show, you'll hear clear, clinically grounded discussions designed for nurse anesthesia residents and CRNAs who want to feel more confident in complex pharmacology, physiology, and real-world anesthesia decision-making.⚠️ SIGN UP FOR OUR FREE NEWSLETTER: [NEWSLETTER SIGN-UP]In this episode:How the larynx functions as a dynamic valve balancing ventilation, airway protection, and phonationFunctional airway anatomy of the supraglottic, glottic, and subglottic regions and why it matters during laryngoscopy and intubationHow laryngeal cartilages and joints (especially the cricoid and arytenoids) drive vocal cord movement and airway patencyClinical patterns of nerve injury (SLN vs RLN) and how they present as hoarseness, aspiration risk, or airway obstructionMechanisms, triggers, and stepwise management of laryngospasm in the perioperative setting

In this episode of the Advancing Surgical Care Podcast, ASCA Chief Executive Officer Bill Prentice leads a conversation about the challenges of providing anesthesia services in surgery centers today. Prentice is joined by Garrett Hilgendorf, administrator of Mankato Surgery Center in Mankato, Minnesota, and Brett Maxfield, CRNA, principal and founder of Maxfield Health Solutions, a provider of anesthesia equipment and consulting services based in Rigby, Idaho. Obtaining anesthesia services has become one of the most complex parts of running a successful ASC today, and striking the right balance between providing high-quality anesthesia care and maintaining financial viability is harder than ever. During this insightful discussion, Hilgendorf and Maxfield talk about how they are innovating and adapting to succeed in this new and challenging environment. Both Hilgendorf and Maxfield will also participate in a panel discussion on managing anesthesia services at the ASCA + SAMBA Conference & Expo in Washington, DC, this May. ASCA's partnership with SAMBA (Society for Ambulatory Anesthesia) for this year's conference will provide a more interdisciplinary learning and networking experience for the entire ASC community.

What if CRNA students could practice critical anesthesia skills over and over again without limits, without pressure, and without risking patient safety? In this episode of Airway Exchange, Louisa and Erin explore how virtual reality is transforming nurse anesthesia education. Joined by Katie Cole, DNP, CRNA, CHSE and Kelly Wiltse Nicely, PhD, CRNA from Emory University, we'll dive into how VR simulation is being integrated into training for foundational skills like intubation, induction sequences, and anesthesia gas machine operation. Here's some of what you'll hear in this episode:

Welcome to the Atomic Anesthesia podcast hosted by CRNA professor Dr. Rhea Temmermand and Co-Founder Sachi Lord. On this show, you'll hear clear, clinically grounded discussions designed for nurse anesthesia residents and CRNAs who want to feel more confident in complex pharmacology, physiology, and real-world anesthesia decision-making.⚠️ SIGN UP FOR OUR FREE NEWSLETTER: [NEWSLETTER SIGN-UP]In this episode:Featuring SRNA Julie (“Grad School Jules”) discussing the emotional realities of CRNA school that students rarely talk aboutThe psychological phases of the CRNA journey from application anxiety to early-semester overwhelmWhy imposter syndrome is so common among SRNAs and how it affects high-achieving studentsUnrealistic expectations students bring into anesthesia school and what the learning curve actually looks likePractical mindset shifts to navigate stress, build resilience, and succeed during the CRNA training journey

What happens when both you and your significant other are on the CRNA journey? In this episode, Cole and Tanner sit down with Connor and Shayla to talk about what it's really like navigating anesthesia school as a couple.From supporting each other, overlapping in school, managing stress, finances, and the day-to-day reality of building a future together in anesthesia, they share what this experience has really looked like behind the scenes. Honest, relatable, and a great reminder that anesthesia school may test a relationship, but it can also strengthen one.Follow along with Connor and Shayla's journey on socials @connorpatrick12 & @shaylaminiterSupport the showTo access all of our content, download the CORE Anesthesia App available here on the App Store and here on Google Play. Want to connect? Check out our instagram or email us at info@coreanesthesia.com 

In this episode, Nicolas and Kelsey sit down with Tarcisio Gois dos Santos, BSN, RN, SRNA an internationally educated nurse from Brazil who is now an SRNA at the Mayo Clinic. As workforce shortages persist, the profession is evolving and hospitals are hiring more nurses educated outside of the United States. We'll explore the realities of applying to CRNA school as an international nurse and discuss the differences in nursing education across countries. Here's some of what we discuss in this episode:

The opioid crisis continues to impact communities across the country, and in many overdose situations, police officers are the first people to arrive on the scene. That reality inspired a powerful community initiative led by CRNA student Krystin Jones. Her DNP project focuses on training law enforcement officers to recognize opioid overdoses and confidently administer naloxone, a medication that can reverse the effects of an overdose and potentially save a life. Here's some of what you'll hear in this episode:

In this episode of Airway Exchange, Jiale (Gary) Hu, PhD, RN, FAAN joins the conversation to explore how AI is reshaping the way we teach, learn, and prepare future CRNAs. He's currently ​the ​Director ​of ​Research ​and ​Global ​Outreach ​in ​the ​Department ​of ​Nurse ​Anesthesia, and his ​scholarship ​focuses ​on ​enhancing ​knowledge ​translation ​in ​healthcare ​environments, ​with ​a ​lot ​of ​his ​current ​projects ​encompassing ​AI ​integration ​in ​healthcare ​education. We'll go beyond theory and into practical implementation of AI, like integrating AI literacy into the curriculum and building custom GPT tools for student handbooks. We also want to address the concerns many educators share: ethical use, institutional support, academic integrity, prompt engineering, and how to keep humans “in the loop.”   Here's some of what you'll hear in this episode:

Welcome to the Atomic Anesthesia podcast hosted by CRNA professor Dr. Rhea Temmermand and Co-Founder Sachi Lord. On this show, you'll hear clear, clinically grounded discussions designed for nurse anesthesia residents and CRNAs who want to feel more confident in complex pharmacology, physiology, and real-world anesthesia decision-making.⚠️ SIGN UP FOR OUR FREE NEWSLETTER: [NEWSLETTER SIGN-UP]In this episode:How opioids produce analgesia by decreasing synaptic transmission in central pain pathways rather than blocking nerve conduction μ, κ, and δ opioid receptor pharmacology and how Gi-coupled GPCR signaling alters calcium, potassium, and cAMP How opioids reduce pain by suppressing ascending nociceptive signaling and enhancing descending inhibitory pathways The physiologic basis of common opioid effects including respiratory depression, sedation, bradycardia, and GI effects

Today's episode is one of courage, survival, and reclaiming your voice. Tonia Bales, CRNA and author of When You See It: How I Outsmarted and Outlasted Dirty John, shares her deeply personal story of manipulation, coercive control, and psychological abuse. While the world knows the headline-grabbing “Dirty John” narrative, this conversation takes us behind the scenes to explore how even strong, capable professionals can be targeted and trapped by someone hiding in plain sight. Here's some of what you'll hear in this episode:

In honor of International Women's Day on March 8, this episode of Grade 1 View highlights the power, resilience, and impact of women shaping the future of nurse anesthesia. Dr. Bimpe ‘Bebe' Adenusi shares her remarkable journey from clinical chemist to CRNA, educator, program director, national leader, and founder of the Nigerian American Nurse Anesthetist Association. With authenticity and humility, she reflects on the mentors who shaped her path, the challenges of stepping into leadership, and the responsibility of lifting the next generation. Here's some of what we discuss in this episode:

Welcome to the Atomic Anesthesia podcast hosted by CRNA professor Dr. Rhea Temmermand and Co-Founder Sachi Lord. On this show, you'll hear clear, clinically grounded discussions designed for nurse anesthesia residents and CRNAs who want to feel more confident in complex pharmacology, physiology, and real-world anesthesia decision-making.⚠️ SIGN UP FOR OUR FREE NEWSLETTER: [NEWSLETTER SIGN-UP]In this episode:Featuring Dr. Jerrol Wallace, DNP, CRNA, FAANA, FAAN, sharing firsthand insight into military nurse anesthesia training and deployment experienceMilitary CRNA training pathway and selection standardsOperational readiness and austere anesthesia environmentsTrauma intensity, deployment medicine, and prolonged field careAutonomy, leadership development, and high-stakes decision-making

Becoming a CRNA isn't just about mastering pharmacology, physiology, and airway skills. It's about mentorship. In this episode of Beyond the Mask, Kelly Elmore, DNP, APRN-CRNA joins the show to discuss one of the most critical and often overlooked elements of nurse anesthesia education: preceptorship training. From bridging classroom theory to real-time clinical decision-making, preceptors are the link between knowledge and confidence. And when that experience goes well, it can shape a career. When it doesn't, it can leave lasting scars. Here's some of what you'll hear in this episode:

Writing for a grade is one thing. Writing to contribute to a scientific conversation is something entirely different. In this episode of Airway Exchange, Dr. Edwin Aroke, an internationally recognized CRNA pain scientist and Editor-in-Chief of the AANA Journal, joins hosts Erin and Nickie to talk with us about scholarly writing and peer review. His ​scholarship ​has ​resulted ​in ​over ​60 ​peer-reviewed ​publications and ​many ​nationally ​and ​internationally ​presentations ​on ​pharmacogenomics, ​pain ​disparities ​and ​anesthesia ​outcomes. This conversation is a practical guide for nurse anesthesia educators who want to elevate their scholarship, as we'll discuss developing a focused research niche to navigating peer review, grant funding, and common reasons for desk rejection. Here's some of what you'll hear in this episode: ✍️ From Classroom Writing to Publication 

Welcome to the Atomic Anesthesia podcast hosted by CRNA professor Dr. Rhea Temmermand and Co-Founder Sachi Lord. On this show, you'll hear clear, clinically grounded discussions designed for nurse anesthesia residents and CRNAs who want to feel more confident in complex pharmacology, physiology, and real-world anesthesia decision-making.⚠️ SIGN UP FOR OUR FREE NEWSLETTER: [NEWSLETTER SIGN-UP]

Reaching a seven-figure net worth isn't just about income—it's about decisions. In this Milestones to Millionaire episode, a CRNA walks through how he built wealth, why he ultimately fired his financial advisor, and the challenges that came with taking full ownership of his financial life. The conversation covers income and net worth context, the emotional and practical hurdles of managing money independently, and how spousal alignment played a role in long-term success. This episode isn't about shortcuts or market timing. It's about clarity, accountability, and the decisions that mattered most on the path to the first million—especially for high-income professionals navigating complex financial choices. If you're a high-income physician, you already know how hard you work for every dollar. The question is: how much are you actually keeping after taxes? Gelt is a tax firm focused on proactive tax strategy, guided by expert CPAs and optimized via in-house AI tools. They work with physicians and practice owners to use the tax code more intelligently so your structure, deductions, and planning help you keep more of what you earn. As a White Coat Investor reader, you can book a free strategy intro at https://joingelt.com and receive 10% off your first year with Gelt. It's time to start using your tax plan as a lever for growth. Celebrating your stories of success along the journey to financial freedom! Tune in every Monday to the Milestones to Millionaire Podcast, where we celebrate the financial achievements of our listeners and share practical tips for reaching your own milestones. We want to celebrate your milestones—no matter how big or small—and help inspire others to follow your lead. Every week, these episodes feature one listener who has recently achieved a milestone they are proud of and want to celebrate, and they give any advice they have for those who want to follow their example. Make sure to listen every Monday to be inspired by your fellow white coat investors. Celebrate YOUR Milestone on the Milestones to Millionaire Podcast: https://whitecoatinvestor.com/milestones  Website: https://www.whitecoatinvestor.com  YouTube: https://www.whitecoatinvestor.com/youtube  Student Loan Advice: https://studentloanadvice.com  TikTok: https://www.tiktok.com/@thewhitecoatinvestor  Facebook: https://www.facebook.com/thewhitecoatinvestor  Twitter: https://twitter.com/WCInvestor  Instagram: https://www.instagram.com/thewhitecoatinvestor  Subreddit: https://www.reddit.com/r/whitecoatinvestor  Online Courses: https://whitecoatinvestor.teachable.com  Newsletter: https://www.whitecoatinvestor.com/free-monthly-newsletter 

Welcome to the Atomic Anesthesia podcast hosted by CRNA professor Dr. Rhea Temmermand and Co-Founder Sachi Lord. On this show, you'll hear clear, clinically grounded discussions designed for nurse anesthesia residents and CRNAs who want to feel more confident in complex pharmacology, physiology, and real-world anesthesia decision-making.⚠️ SIGN UP FOR OUR FREE NEWSLETTER: [NEWSLETTER SIGN-UP]

Welcome to the Atomic Anesthesia podcast hosted by CRNA professor Dr. Rhea Temmermand and Co-Founder Sachi Lord. On this show, you'll hear clear, clinically grounded discussions designed for nurse anesthesia residents and CRNAs who want to feel more confident in complex pharmacology, physiology, and real-world anesthesia decision-making.⚠️ SIGN UP FOR OUR FREE NEWSLETTER: [NEWSLETTER SIGN-UP]

CRNAs are in demand. Salaries are strong. Jobs are plentiful. So why is Dr. Randy Moore sounding the alarm? In this episode, Randy joins Sharon and guest host Kevin Chem, DNP, CRNA to unpack his viral Substack article, “No One Is Coming to Save Us.” The core message is uncomfortable but clear: while anesthesia organizations remain divided over turf and titles, payers are quietly reshaping reimbursement policy in ways that could have long-term consequences for both CRNAs and anesthesiologists. Here's some of what you'll hear in this episode:

In this special episode, the conversation goes beyond anesthesia, leadership, and practice models and into something just as essential: friendship, health, and wellness. In a profession that is demanding, high‑stakes, and often isolating, the relationships CRNAs build with one another can be a powerful source of strength. Sharon is  joined by longtime friends Jackie Rowles, DNP, MBA, MA, CRNA, ANP-BC, NSPM-C, FNAP, FAANA, FAAN, Tracy Castleman,  DNP, CRNA, APN-A, FAANA, and Carole Doyscher, CRNA, BSN, MS, APRN—four CRNAs whose bond, known affectionately as the Fab Four, was forged through shared experiences, mutual respect, and plenty of laughter along the way. Together, they reflect on how authentic connection within the CRNA community supports resilience, personal well‑being, and professional longevity. Here's some of what you'll hear in this episode:

Recorded live at the EDGE Conference, this special episode brings all four hosts together for an honest, reflective conversation about what makes this meeting so meaningful for CRNA educators, and why it continues to matter more than ever. Here's some of what you'll hear in this episode:

Most anesthesia providers spend years building a highly specialized skill set, then assume the only path forward is “more OR.” But what if your CRNA degree could open doors beyond the head of the bed?In this episode, Cole and Tanner sit down with Randy Moore for an honest conversation about the broader world of anesthesia careers. Together, they explore:What “beyond the head of the bed” really means for CRNAsCareer opportunities outside traditional OR rolesHow to think about your CRNA skill set as transferable (leadership, education, consulting, and more)Why exploring non-traditional paths can add flexibility, longevity, and fulfillment to your careerWhether you're early in your CRNA journey, starting to feel the pull toward something different, or just want to expand your perspective, this conversation will help you see the profession with wider angles.Subscribe to Randy's free resource, Inside Anesthesia, at https://randymoore.substack.comSupport the showTo access all of our content, download the CORE Anesthesia App available here on the App Store and here on Google Play. Want to connect? Check out our instagram or email us at info@coreanesthesia.com

Incivility doesn't always announce itself loudly—it often creeps in quietly, becoming normalized in high-stress clinical environments. In this episode, Lynn and Garry are joined by leadership veteran Meri Gilman-Mays, CRNA, DNP to continue a candid conversation on addressing incivility in nurse anesthesia. Part two of this conversation shifts from recognizing incivility to actively addressing it through leadership. We'll challenge the notion that leadership requires a title, highlighting how CRNAs lead daily at the bedside, in the operating room, and through committee work. Listeners are invited to consider the impact of silence versus intervention and how modeling professionalism under pressure influences team culture. After listening to this episode, participants will be able to: Identify leadership behaviors that CRNAs can demonstrate regardless of formal title or position. Apply real-time de-escalation strategies to address incivility while maintaining professionalism and authority. Utilize a structured framework for conducting difficult follow-up conversations and ensuring accountability. Describe strategies for fostering a culture of respect and psychological safety within anesthesia and perioperative teams. Visit us online: https://beyondthemaskpodcast.com/ The 1099 CRNA Institute: https://aana.com/1099 Get the CE Certificate here (and directly submit to the NBCRNA): https://beyondthemaskpodcast.com/wp-content/uploads/2020/04/Beyond-the-Mask-CE-Cert-FILLABLE.pdf Help us grow by leaving a review: https://podcasts.apple.com/us/podcast/beyond-the-mask-innovation-opportunities-for-crnas/id1440309246 Now you can watch the show on YouTube! Check it out here: https://www.youtube.com/channel/UCknrmkRxiwtYk7LUjSV6wmw?sub_confirmation=1

Representation in nurse anesthesia is about access, excellence, and belonging. It's the responsibility of every CRNA to help shape the future of the profession in a way that affords opportunity and access to anyone who wants to pursue that goal. In this episode, hosts Nicolas and Kelsey are joined by two influential leaders in nurse anesthesia advocacy, Lena Gould, EdD, CRNA, FADLN, FAANA, FAAN and Vincent Ford, DNAP, CRNA, to talk candidly about diversity, mentorship, and responsibility. Here's some of what we discuss in this episode:

From the very beginning of nurse anesthesia, opposition was organized, strategic, and relentless. Two central figures who devoted their careers to making anesthesia a physician-only specialty in the United States in the early 1900s were Frank and Laurette McMechan. Today, we'll examine their lives and professional impact in this historical episode with our show historians Nancy Bruton-Maree, CRNA and Sandy Ouellette, CRNA. Here's some of what you'll hear in this episode: